HI

Healthcare · Pharmaceuticals

Hikal Ltd (HIKAL)

₹220.76

Mkt cap
₹2,743 Cr
P/E ratio
38.50
P/B
2.30
Div yield
0.27%
ROE
2.21%
ROCE
3.50%
EPS (TTM)
₹5.73
Book value
₹96
52W range
146–261
Sector
Healthcare

Price history

Previous close

Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune. [1]

NSE HIKALBSE 524735
Health check
Mixed
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsBullish
52-week range
−15.42% from high
₹221
₹146+50.95% from low₹261
Current
₹220.76
Prev close
₹222.06
Day
−0.59%
Price performance
1D
+0.07%
1W
−0.11%
1M
+9.37%
3M
+4.69%
6M
+8.14%
1Y
−3.71%
YTD
−2.73%

Financials

Revenue, profit & margin
P/E ratio
38.5×
HIKAL is 13% above the sector median of 34.0×
HIKAL38.5×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales434.88447.50514.10406.80452.90447.70552.40380.40318.50494.30519.40402.80434.20
YoY Sales growth-22.17%-17.16%-5.72%+4.85%+4.14%+0.04%+7.45%-6.49%-29.68%+10.41%-5.97%+5.89%+36.33%
Expenses377.36382.80419.70348.80378.00375.60429.00355.30311.30411.60414.00365.80389.30
Operating Profit57.5264.7094.4058.0074.9072.10123.4025.107.2082.70105.4037.0044.90
OPM %13.23%14.46%18.36%14.26%16.54%16.10%22.34%6.60%2.26%16.73%20.29%9.19%10.34%
Other Income0.990.100.500.500.403.600.501.001.90-35.20-40.5010.701.70
Interest13.0814.2015.3019.8018.8018.7017.9017.1014.9015.5014.6014.9013.40
Depreciation28.5729.0032.3031.8031.7033.2037.7039.4041.2041.2042.0042.7041.70
Profit before tax16.8621.6047.306.9024.8023.8068.30-30.40-47.00-9.208.30-9.90-8.50
Tax %25.44%25.46%28.33%26.09%26.21%27.73%26.50%-26.32%-25.74%-35.87%-73.49%-25.25%-28.24%
Net Profit12.5716.1033.905.1018.3017.2050.20-22.40-34.90-5.9014.40-7.40-6.10
EPS in Rs1.021.312.750.411.481.394.07-1.82-2.83-0.481.17-0.60-0.49
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +3.18% · closed higher next day 2 of last 2
 Q1FY27Q2FY27
Broadcast6 Aug '263 Nov '26
Earnings day+2.58%+3.78%
+1 day+1.49%+2.97%
+5 days−1.55%+4.23%
+15 days−7.77%—
+30 days+3.49%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
68.85%Promoter
Promoters68.85%
FIIs1.28%0.30
DIIs5.31%1.92
Public24.57%1.65
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Hikal₹222.4738.532,7430.27%−6+82.52%434+36.33%3.50%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings